{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:27:02Z","timestamp":1791332822816,"version":"4.3.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Doctoral Fund of the Second Hospital of Shanxi Medical University","award":["No.202001-4"],"award-info":[{"award-number":["No.202001-4"]}]},{"name":"Natural Science Research Project of Shanxi Province","award":["No. 20210302123281"],"award-info":[{"award-number":["No. 20210302123281"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Primary Sjogren\u2019s syndrome (pSS) is a heterogeneous chronic autoimmune disorder characterized by lymphocyte infiltration of the exocrine glands and the involvement and dysfunction of multiple organs and tissues. Interstitial lung disease (ILD) is the most common type of respiratory system damage. This study ascertained the factors related to ILD in patients with pSS (pSS-ILD), such as altered levels of circulating lymphocyte subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Eighty healthy controls and 142 patients diagnosed with pSS were included. The pSS patients were classified into groups with pSS-ILD or pSS without ILD (pSS-non-ILD). Baseline clinical and laboratory data were collected for all subjects, including the levels of lymphocytes measured by modified flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The pSS-ILD patients were older, had higher ESSDAI scores, had higher positivity rates for anti-SSB and anti-Ro52 antibodies, and had more frequent symptoms of respiratory system involvement than pSS-non-ILD patients. pSS-ILD patients had the lowest Th2 cell counts among the three groups. Although the absolute numbers of Treg and NK cells were lower in pSS patients with and without ILD than in the healthy controls, there was no significant difference between the two pSS groups. The Th1\/Th2 ratio was significantly higher in patients with ILD than in patients without ILD. Further analysis showed that older age (OR=1.084), lower Th2 count (OR=0.947), higher Th1\/Th2 ratio (OR=1.021), and positivity for anti-SSB (OR=3.620) and anti-Ro52 (OR=5.184) antibodies were associated with the occurrence of ILD in patients with pSS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Decreased circulating Th2 cells and an elevated Th1\/Th2 ratio may be the immunological mechanism underlying the development of ILD in pSS patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-022-02811-z","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T05:03:21Z","timestamp":1653282201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Circulating Th2 cell reduction and Th1\/Th2 imbalance are correlated with primary Sjogren\u2019s syndrome-associated interstitial lung disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Lei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Xia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Lei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"issue":"1","key":"2811_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12952-017-0069-0","volume":"16","author":"B Efared","year":"2017","unstructured":"Efared B, Ebang-Atsame G, Rabiou S, et al. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases. J Negat Results Biomed. 2017;16(1):4. https:\/\/doi.org\/10.1186\/s12952-017-0069-0.","journal-title":"J Negat Results Biomed"},{"issue":"4","key":"2811_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/ar3097","volume":"12","author":"FV Castelino","year":"2010","unstructured":"Castelino FV, Varga J. Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management. Arthritis Res Ther. 2010;12(4):213. https:\/\/doi.org\/10.1186\/ar3097.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"2811_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1158\/1055-9965.EPI-04-0624","volume":"14","author":"Z Amoura","year":"2005","unstructured":"Amoura Z, Duhaut P, Huong DL, et al. Tumor antigen markers for the detection of solid cancers in inflammatory myopathies. Cancer Epidemiol Biomarkers Prev. 2005;14(5):1279\u201382. https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0624.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"2811_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/ard.59.9.709","volume":"59","author":"BK Davidson","year":"2000","unstructured":"Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2000;59(9):709\u201312. https:\/\/doi.org\/10.1136\/ard.59.9.709.","journal-title":"Ann Rheum Dis"},{"key":"2811_CR5","doi-asserted-by":"publisher","first-page":"h6819","DOI":"10.1136\/bmj.h6819","volume":"352","author":"SC Mathai","year":"2016","unstructured":"Mathai SC, Danoff SK. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819. https:\/\/doi.org\/10.1136\/bmj.h6819.","journal-title":"BMJ"},{"issue":"11","key":"2811_CR6","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10067-018-4289-6","volume":"37","author":"X Dong","year":"2018","unstructured":"Dong X, Zhou J, Guo X, et al. A Retrospective analysis of distinguishing features of chest hrct and clinical manifestation in primary Sjogren\u2019s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol. 2018;37(11):2981\u20138. https:\/\/doi.org\/10.1007\/s10067-018-4289-6.","journal-title":"Clin Rheumatol"},{"key":"2811_CR7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3389\/fimmu.2019.01327","volume":"10","author":"S Gupta","year":"2019","unstructured":"Gupta S, Ferrada MA, Hasni SA. Pulmonary manifestations of primary Sjogren\u2019s syndrome: underlying immunological mechanisms, clinical presentation, and management. Front Immunol. 2019;10:1327. https:\/\/doi.org\/10.3389\/fimmu.2019.01327.","journal-title":"Front Immunol"},{"issue":"10","key":"2811_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the Eular Scleroderma Trials and Research (Eustar) database. Ann Rheum Dis. 2010;69(10):1809\u201315. https:\/\/doi.org\/10.1136\/ard.2009.114264.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2811_CR9","first-page":"587","volume":"34","author":"T Wang","year":"2016","unstructured":"Wang T, Zheng XJ, Ji YL, et al. Tumour markers in rheumatoid arthritis-associated interstitial lung disease. Clin Exp Rheumatol. 2016;34(4):587\u201391.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2811_CR10","first-page":"170","volume":"112","author":"DB Chandler","year":"1983","unstructured":"Chandler DB, Hyde DM, Giri SN. Morphometric estimates of infiltrative cellular changes during the development of bleomycin-induced pulmonary fibrosis in hamsters. Am J Pathol. 1983;112(2):170\u20137.","journal-title":"Am J Pathol"},{"issue":"2","key":"2811_CR11","first-page":"279","volume":"129","author":"RS Thrall","year":"1984","unstructured":"Thrall RS, Barton RW. A comparison of lymphocyte populations in lung tissue and in bronchoalveolar lavage fluid of rats at various times during the development of bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis. 1984;129(2):279\u201383.","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"2811_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"MI Christodoulou","year":"2010","unstructured":"Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the Minor salivary gland infiltrates in Sjogren\u2019s syndrome. J Autoimmun. 2010;34(4):400\u20137. https:\/\/doi.org\/10.1016\/j.jaut.2009.10.004.","journal-title":"J Autoimmun"},{"issue":"12","key":"2811_CR13","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1136\/annrheumdis-2018-213036","volume":"77","author":"M Miao","year":"2018","unstructured":"Miao M, Hao Z, Guo Y, et al. Short-term and low-dose Il-2 therapy restores the Th17\/Treg balance in the peripheral blood of patients with primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2018;77(12):1838\u201340. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213036.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2811_CR14","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren\u2019s syndrome: a revised version of the european criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554\u20138. https:\/\/doi.org\/10.1136\/ard.61.6.554.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2811_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology\/European League against Rheumatism Classification Criteria for Primary Sjogren\u2019s Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9\u201316. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210571.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"2811_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","volume":"183","author":"G Raghu","year":"2011","unstructured":"Raghu G, Collard HR, Egan JJ, et al. An Official Ats\/Ers\/Jrs\/Alat Statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824. https:\/\/doi.org\/10.1164\/rccm.2009-040GL.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2811_CR17","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3760\/cma.j.issn.0578-1426.2018.08.005","volume":"57","author":"Q Wang","year":"2018","unstructured":"Wang Q, Li M. 2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases. Chi J Intern Med. 2018;57(8):558\u201365. https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1426.2018.08.005.","journal-title":"Chi J Intern Med"},{"key":"2811_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2040622320916014","volume":"11","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang SX, Hao YF, et al. The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2. Ther Adv Chronic Dis. 2020;11:1\u201312. https:\/\/doi.org\/10.1177\/2040622320916014.","journal-title":"Ther Adv Chronic Dis"},{"key":"2811_CR19","doi-asserted-by":"publisher","first-page":"204062232094480","DOI":"10.1177\/2040622320944802","volume":"11","author":"L Shi","year":"2020","unstructured":"Shi L, Han XL, Guo HX, et al. Increases in tumor markers are associated with primary Sjogren\u2019s syndrome-associated interstitial lung disease. Ther Adv Chronic Dis. 2020;11:2040622320944802. https:\/\/doi.org\/10.1177\/2040622320944802.","journal-title":"Ther Adv Chronic Dis"},{"issue":"9","key":"2811_CR20","doi-asserted-by":"publisher","first-page":"e73774","DOI":"10.1371\/journal.pone.0073774","volume":"8","author":"Y Enomoto","year":"2013","unstructured":"Enomoto Y, Takemura T, Hagiwara E, et al. Prognostic factors in interstitial lung disease associated with primary Sjogren\u2019s syndrome: a retrospective analysis of 33 pathologically-proven cases. PLoS One. 2013;8(9):e73774. https:\/\/doi.org\/10.1371\/journal.pone.0073774.","journal-title":"PLoS One"},{"issue":"4","key":"2811_CR21","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.21037\/jtd.2018.03.120","volume":"10","author":"Y Wang","year":"2018","unstructured":"Wang Y, Hou Z, Qiu M, et al. Risk factors for primary Sjogren syndrome-associated interstitial lung disease. J Thorac Dis. 2018;10(4):2108\u201317. https:\/\/doi.org\/10.21037\/jtd.2018.03.120.","journal-title":"J Thorac Dis"},{"issue":"2","key":"2811_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cyto.2014.06.008","volume":"69","author":"R Zhang","year":"2014","unstructured":"Zhang R, Sun T, Song L, et al. Increased levels of serum galectin-3 in patients with primary Sjogren\u2019s syndrome: associated with interstitial lung disease. Cytokine. 2014;69(2):289\u201393. https:\/\/doi.org\/10.1016\/j.cyto.2014.06.008.","journal-title":"Cytokine"},{"issue":"1","key":"2811_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/rheumatology\/kes311","volume":"52","author":"O Palm","year":"2013","unstructured":"Palm O, Garen T, Berge Enger T, et al. Clinical pulmonary involvement in primary Sjogren\u2019s syndrome: prevalence, quality of life and mortality--a retrospective study based on registry data. Rheumatology (Oxford). 2013;52(1):173\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kes311.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"2811_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00296-009-1152-8","volume":"30","author":"V Yazisiz","year":"2010","unstructured":"Yazisiz V, Arslan G, Ozbudak IH, et al. Lung involvement in patients with primary Sjogren\u2019s syndrome: what are the predictors? Rheumatol Int. 2010;30(10):1317\u201324. https:\/\/doi.org\/10.1007\/s00296-009-1152-8.","journal-title":"Rheumatol Int"},{"issue":"5","key":"2811_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.reuma.2015.10.010","volume":"12","author":"R Menor Almagro","year":"2016","unstructured":"Menor Almagro R, Jurado Roger A, Rodriguez Gutierrez FJ, et al. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain. Reumatol Clin. 2016;12(5):256\u201362. https:\/\/doi.org\/10.1016\/j.reuma.2015.10.010.","journal-title":"Reumatol Clin"},{"issue":"1","key":"2811_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/cei.12341","volume":"177","author":"LA Aqrawi","year":"2014","unstructured":"Aqrawi LA, Kvarnstrom M, Brokstad KA, et al. Ductal epithelial expression of Ro52 correlates with inflammation in salivary glands of patients with primary Sjogren\u2019s syndrome. Clin Exp Immunol. 2014;177(1):244\u201352. https:\/\/doi.org\/10.1111\/cei.12341.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"2811_CR27","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/1756-185X.13334","volume":"21","author":"H Gao","year":"2018","unstructured":"Gao H, Zou YD, Zhang XW, et al. Interstitial Lung disease in non-sicca onset primary Sjogren\u2019s syndrome: a large-scale case-control study. Int J Rheum Dis. 2018;21(7):1423\u20139. https:\/\/doi.org\/10.1111\/1756-185X.13334.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"2811_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2353\/ajpath.2006.051160","volume":"169","author":"T Kimura","year":"2006","unstructured":"Kimura T, Ishii Y, Yoh K, et al. Overexpression of the transcription factor Gata-3 enhances the development of pulmonary fibrosis. Am J Pathol. 2006;169(1):96\u2013104. https:\/\/doi.org\/10.2353\/ajpath.2006.051160.","journal-title":"Am J Pathol"},{"issue":"4","key":"2811_CR29","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1378\/chest.128.4.2971","volume":"128","author":"SA Papiris","year":"2005","unstructured":"Papiris SA, Kollintza A, Kitsanta P, et al. Relationship of Bal and lung tissue Cd4+ and Cd8+ T lymphocytes, and their ratio in idiopathic pulmonary fibrosis. Chest. 2005;128(4):2971\u20137. https:\/\/doi.org\/10.1378\/chest.128.4.2971.","journal-title":"Chest"},{"issue":"5","key":"2811_CR30","first-page":"765","volume":"27","author":"F Meloni","year":"2009","unstructured":"Meloni F, Solari N, Cavagna L, et al. Frequency of Th1, Th2 and Th17 producing T lymphocytes in bronchoalveolar lavage of patients with systemic sclerosis. Clin Exp Rheumatol. 2009;27(5):765\u201372.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"2811_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1164\/rccm.200502-244OC","volume":"173","author":"P Pignatti","year":"2006","unstructured":"Pignatti P, Brunetti G, Moretto D, et al. Role of the chemokine receptors Cxcr3 and Ccr4 in human pulmonary fibrosis. Am J Respir Crit Care Med. 2006;173(3):310\u20137. https:\/\/doi.org\/10.1164\/rccm.200502-244OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2811_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10238-020-00623-6","volume":"20","author":"L Shi","year":"2020","unstructured":"Shi L, Fu Q, Chen N, et al. Angiopoietin-like protein 2 as a novel marker for patients with primary Sjogren\u2019s syndrome-related interstitial lung disease. Clin Exp Med. 2020;20(3):393\u20139. https:\/\/doi.org\/10.1007\/s10238-020-00623-6.","journal-title":"Clin Exp Med"},{"issue":"5","key":"2811_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.lab.2006.01.001","volume":"147","author":"Y Izumi","year":"2006","unstructured":"Izumi Y, Ida H, Huang M, et al. Characterization of peripheral natural killer cells in primary Sjogren\u2019s syndrome: impaired Nk cell activity and low Nk cell number. J Lab Clin Med. 2006;147(5):242\u20139. https:\/\/doi.org\/10.1016\/j.lab.2006.01.001.","journal-title":"J Lab Clin Med"},{"issue":"10","key":"2811_CR34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nri911","volume":"2","author":"JA Trapani","year":"2002","unstructured":"Trapani JA, Smyth MJ. Functional significance of the perforin\/granzyme cell death pathway. Nat Rev Immunol. 2002;2(10):735\u201347. https:\/\/doi.org\/10.1038\/nri911.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2811_CR35","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1136\/jcp.2003.015495","volume":"57","author":"H Miyazaki","year":"2004","unstructured":"Miyazaki H, Kuwano K, Yoshida K, et al. The perforin mediated apoptotic pathway in lung injury and fibrosis. J Clin Pathol. 2004;57(12):1292\u20138. https:\/\/doi.org\/10.1136\/jcp.2003.015495.","journal-title":"J Clin Pathol"},{"issue":"5","key":"2811_CR36","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/art.24435","volume":"60","author":"IG Luzina","year":"2009","unstructured":"Luzina IG, Todd NW, Nacu N, et al. Regulation of pulmonary inflammation and fibrosis through expression of integrins alphavbeta3 and alphavbeta5 on pulmonary T lymphocytes. Arthritis Rheum. 2009;60(5):1530\u20139. https:\/\/doi.org\/10.1002\/art.24435.","journal-title":"Arthritis Rheum"},{"issue":"Pt 4","key":"2811_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/BST0350661","volume":"35","author":"J Gauldie","year":"2007","unstructured":"Gauldie J, Bonniaud P, Sime P, et al. Tgf-Beta, Smad3 and the process of progressive fibrosis. Biochem Soc Trans. 2007;35(Pt 4):661\u20134. https:\/\/doi.org\/10.1042\/BST0350661.","journal-title":"Biochem Soc Trans"},{"issue":"6","key":"2811_CR38","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00296-012-2561-7","volume":"33","author":"L Zhang","year":"2013","unstructured":"Zhang L, Mo H, Zhu M, et al. Effect of cyclophosphamide on cytokines in patients with primary Sjogren\u2019s syndrome-associated interstitial lung disease in South China. Rheumatol Int. 2013;33(6):1403\u20137. https:\/\/doi.org\/10.1007\/s00296-012-2561-7.","journal-title":"Rheumatol Int"},{"issue":"3","key":"2811_CR39","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2249.1998.00705.x","volume":"114","author":"M Polihronis","year":"1998","unstructured":"Polihronis M, Tapinos NI, Theocharis SE, et al. Modes of epithelial cell death and repair in Sjogren\u2019s syndrome (Ss). Clin Exp Immunol. 1998;114(3):485\u201390. https:\/\/doi.org\/10.1046\/j.1365-2249.1998.00705.x.","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"2811_CR40","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1136\/ard.2005.049924","volume":"65","author":"A Suarez","year":"2006","unstructured":"Suarez A, Lopez P, Gomez J, et al. Enrichment of Cd4+ Cd25high T cell population in patients with systemic lupus erythematosus treated with glucocorticoids. Ann Rheum Dis. 2006;65(11):1512\u20137. https:\/\/doi.org\/10.1136\/ard.2005.049924.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"2811_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1748-5827.2011.01024.x","volume":"52","author":"NT Whitley","year":"2011","unstructured":"Whitley NT, Day MJ. Immunomodulatory drugs and their application to the management of canine immune-mediated disease. J Small Anim Pract. 2011;52(2):70\u201385. https:\/\/doi.org\/10.1111\/j.1748-5827.2011.01024.x.","journal-title":"J Small Anim Pract"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02811-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-022-02811-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-022-02811-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T05:20:57Z","timestamp":1653283257000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-022-02811-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2811"],"URL":"https:\/\/doi.org\/10.1186\/s13075-022-02811-z","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"4 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Second Hospital of Shanxi Medical University (2016 KY-007).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The data was anonymous, and the requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}